Omni Partners US LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 39 filers reported holding IBERE PHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Omni Partners US LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q3 2021$567,000
-20.9%
58,552
-21.0%
0.03%
-9.4%
Q2 2021$717,000–74,143–0.03%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q3 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders